<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B936D768-A528-4ABB-A6FA-D5F91D6FD0F4"><gtr:id>B936D768-A528-4ABB-A6FA-D5F91D6FD0F4</gtr:id><gtr:name>Defence Science &amp; Technology Laboratory (DSTL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Statistical Sciences Research institute</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B936D768-A528-4ABB-A6FA-D5F91D6FD0F4"><gtr:id>B936D768-A528-4ABB-A6FA-D5F91D6FD0F4</gtr:id><gtr:name>Defence Science &amp; Technology Laboratory (DSTL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/536116AC-C155-4A24-A743-309BD68E50CE"><gtr:id>536116AC-C155-4A24-A743-309BD68E50CE</gtr:id><gtr:name>Defence Science &amp; Tech Lab DSTL</gtr:name><gtr:address><gtr:line1>Defence Science &amp; Tech Lab - MOD</gtr:line1><gtr:line2>Porton Down</gtr:line2><gtr:line4>Salisbury</gtr:line4><gtr:postCode>SP4 0JQ</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5B9542CC-D7F0-45DA-A423-16458386EA25"><gtr:id>5B9542CC-D7F0-45DA-A423-16458386EA25</gtr:id><gtr:name>GlaxoSmithKline PLC</gtr:name><gtr:address><gtr:line1>Park Road</gtr:line1><gtr:postCode>SG12 0DP</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9FFF87EF-4080-42EF-BC0B-E06430F137EA"><gtr:id>9FFF87EF-4080-42EF-BC0B-E06430F137EA</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Woods</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FJ018317%2F1"><gtr:id>AD808585-ECC0-4448-B56B-8799D0C3CD8C</gtr:id><gtr:title>Statistical Design of Experiments for Complex Nonparametric and Mechanistic Models</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>EP/J018317/1</gtr:grantReference><gtr:abstractText>Experiments are used to investigate the impact on an observed response of a set of controllable features (called factors or variables) of the system under study, and provide the basis of much important research in many areas of the physical sciences, engineering and industry. Design of experiments is concerned with selecting the combinations of factor values, or treatments, to be run to meet the aims of the experiment with best use of resource. These aims will usually involve learning about the unknown relationship between the response and the factors, and then building a statistical model to approximate this relationship. Such a model describes how changing the factor values affects the response and the nature of the uncertainty in the relationship arising from sources such as measurement error. Importantly, the model allows us to predict the response from the system for an unobserved treatment, and to quantify our uncertainty about the prediction. 

This research programme aims to develop new methods of finding good designs under a variety of different assumptions about the type of statistical model to be estimated from the experiment data in the presence of complicated structures in the data collection process. There are three research themes and, for each, new designs will be found that allow us to learn efficiently and effectively about different types of statistical models. In the first theme, we have little prior scientific knowledge about the system, and hence we cannot specify a form of statistical model in advance of the experiment. In the second theme, designs will be found for experiments where, for each treatment, we observe a curve or surface, representing a function, rather than a single number. We then need to learn about the form of this function for each treatment, and how the functions vary from treatment to treatment. The third theme will consider systems where one or more scientific theories may provide a mathematical approximation to the responses of interest. Here, a design is needed to generate data that enables discrimination between the competing theories and understanding of the difference, or discrepancy, between scientific theory and the real system. 

Methodological research in the design of experiments has been traditionally motivated by problems from science, medicine and engineering. The research on the three themes is motivated by experimental programmes from pharmaceutical development, engineering and dispersion science. The new designs found will be test-bedded in prototype experiments in these fields through interactions with project partners and scientific collaborators. These experiments will provide a valuable evaluation of the methods and demonstrate their effectiveness to user communities. The methods will also have wider impact across a range of sciences and industry where such experiments are required and where there are currently no designs available tailored to both the aims of the experiment and the methods to be used in the data analysis.</gtr:abstractText><gtr:potentialImpactText>The statistical design of experiments is crucial to the discovery of new knowledge in many fields of science and engineering. Those working in fields involving advanced technology and experiment techniques will potentially benefit from the optimal designs and methods developed in the research programme. They will be able to obtain data tailored to sophisticated modelling techniques, including understanding of uncertainties, and appropriate to their scientific aims. Importantly, the designs will make best use of resources, leading to efficient experiments.

Many industries are concerned with using experimental programmes to develop and manufacture products and processes with consistently high performance They are potential beneficiaries of the research through the availability of the new efficient tailored designs. This benefit leads to reduced cost of materials and faster time-to-market, offering the long-term prospect of improving UK economic competitiveness. Project partner GlaxoSmithKline and other pharmaceutical companies may make such gains in the development and manufacturing of new drugs. Collaborations with the Optoelectronics Research Centre and the National Centre for Advanced Tribology will lead to potential impact in other industries including communications, where technologies in fibre optics are leading the broadband revolution, and energy and transport through the generation of new lubricant technologies.

The research has potential societal impact by underpinning scientific advances that improve the quality of life and healthcare in the UK through the faster development of medicines. Societal impact would also come from application by Dstl of the new techniques to develop improved methods for sequential virtual and physical experiments to understand chemical and biological dispersion, thereby decreasing the time taken to react to a terrorist attack.

Interaction with project partners and collaborators provide the opportunity to transfer new statistical methods and techniques to other scientists, leading to an increase in the knowledge and skill-base amongst scientists and statisticians working in the collaborating organisations and centres. 

In all the above fields, experiments are typically complex and involve the measurement of responses which require advanced statistical modelling techniques. There are currently no generic optimal or highly efficient designs available that are tailored to these types of experiments. The proposed research will provide the first bespoke designs and methods for these fast moving application areas, and others with similar types of experimentation, and hence enable greater scientific understanding than currently possible.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-09-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2012-09-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>390712</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Defence Science &amp; Technology Laboratory (DSTL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dstl</gtr:description><gtr:id>63484EAA-096F-4283-86C9-4A9AA9AF2C11</gtr:id><gtr:impact>Bowman &amp;amp; Woods (2013). Weighted space-filling designs. Journal of Simulation, 7, 249-263.</gtr:impact><gtr:outcomeId>545e23efae70d3.39571921-1</gtr:outcomeId><gtr:partnerContribution>Dstl provide the scientific challenge and subject area expertise, and collaborate on the statistical research.</gtr:partnerContribution><gtr:piContribution>Collaborations with Dstl have focused on computer experiments and uncertainty quantification. Methods have been developed and applied for both statistical design and modelling for atmospheric dispersion computer models</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK</gtr:description><gtr:id>4435507E-8CBF-4198-A64E-916F6BC6977E</gtr:id><gtr:impact>No published outputs to date.</gtr:impact><gtr:outcomeId>545e231bc6b8c8.57942873-1</gtr:outcomeId><gtr:partnerContribution>GSK have provided industrial problems, pharmaceutical chemical science expertise and feedback on implemented methods.</gtr:partnerContribution><gtr:piContribution>A variety of research projects and impact activities have taken place with GSK, including the development and application of (i) sequential design of experiments methods for nonparametric regression, (ii) statistical design and modelling methods for screening experiments, and (iii) Bayesian design and modelling methods for multi-stage split-plot experiments.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>31447</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Institutional Sponsorship for research collaboration</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>0E15E7F6-25DE-4159-AE25-81C2B7E4B7CD</gtr:id><gtr:outcomeId>58ac48462092f6.70213698</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>66000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GlaxoSmithKline Product Development Collaboration funding</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>EEF6EB42-C1B9-4645-BBC5-089683DC9A54</gtr:id><gtr:outcomeId>56bc98078b58a1.91472448</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Knowledge Transfer Secondment</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>E3655B3F-0D8B-48EE-8628-E5C62947E159</gtr:id><gtr:outcomeId>54529c2deede89.36492494</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>973523</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Closed loop optimisation for sustainable chemical manufacture</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/L003309/1</gtr:fundingRef><gtr:id>9E63EC42-EA2B-4B93-8D15-3CE3A65DFF25</gtr:id><gtr:outcomeId>5edc9c7e5edc9c92</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8760</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society International Exchange Scheme</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>12B625D3-1BA2-4587-9EF2-BECA8ABE41B2</gtr:id><gtr:outcomeId>58ac48ffa3b382.00501286</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Collaborators in the pharmaceutical industry have used methodology from this project to design and analyse experiments to advance (i) formulated medicines, and (ii) inhaled medicine products.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>6DFC4AA7-2EA6-4DA6-86C0-F6FEBE1DF763</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56bc99be54feb7.25310663</gtr:outcomeId><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>AN R package to find optimal Bayesian designs, implementing the methods in Overstall and Woods (2017, Technometrics)</gtr:description><gtr:id>D02AC7C2-D009-46BE-8F17-B1B5DCF30925</gtr:id><gtr:impact>Provides the first implementation of general methods for finding Bayesian optimal designs for multi-factor experiments.</gtr:impact><gtr:outcomeId>58ac578e559084.28748897</gtr:outcomeId><gtr:title>R package acebayes</gtr:title><gtr:type>Software</gtr:type><gtr:url>https://cran.r-project.org/web/packages/acebayes/index.html</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2C4D9FAA-50F2-4BDD-91F3-BBC5D34BE0A2</gtr:id><gtr:title>Screening Strategies in the Presence of Interactions</gtr:title><gtr:parentPublicationTitle>Technometrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b20d3c82e3f969e922f9a8f32348bcbe"><gtr:id>b20d3c82e3f969e922f9a8f32348bcbe</gtr:id><gtr:otherNames>Draguljic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54185faa93fa68.64049002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2829BFB0-E3DA-45D6-A087-39AF915060EC</gtr:id><gtr:title>Multivariate emulation of computer simulators: model selection and diagnostics with application to a humanitarian relief model.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society. Series C, Applied statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0640257da208e905db9f4ca7f6ca22fb"><gtr:id>0640257da208e905db9f4ca7f6ca22fb</gtr:id><gtr:otherNames>Overstall AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0035-9254</gtr:issn><gtr:outcomeId>585d440145bbe2.96529003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA6EA7D2-5378-45FA-A60A-17B83C3A0DB3</gtr:id><gtr:title>Bayesian design of experiments for generalised linear models and dimensional analysis with industrial and scientific application</gtr:title><gtr:parentPublicationTitle>Quality Engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7284c33dcd450b4d41fa570a391cd461"><gtr:id>7284c33dcd450b4d41fa570a391cd461</gtr:id><gtr:otherNames>Woods D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58ac471d680f82.27712037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19A4BA20-9BDD-47F0-A17E-4DAE8208B3FB</gtr:id><gtr:title>Handbook of the design and analysis of experiments: designs for generalized linear models</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90f84fc3a2d06813fca75cc85c65035c"><gtr:id>90f84fc3a2d06813fca75cc85c65035c</gtr:id><gtr:otherNames>Atkinson, A.C.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:isbn>9781466504332</gtr:isbn><gtr:outcomeId>r_55752025336411c9b2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEFAD92D-B2D8-47F1-9105-06464DC0EAB7</gtr:id><gtr:title>Model selection via Bayesian information capacity designs for generalised linear models</gtr:title><gtr:parentPublicationTitle>Computational Statistics &amp; Data Analysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7284c33dcd450b4d41fa570a391cd461"><gtr:id>7284c33dcd450b4d41fa570a391cd461</gtr:id><gtr:otherNames>Woods D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>585d64caceb523.18515961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>257960B7-C0D4-4A03-ADE5-51FCD77C7543</gtr:id><gtr:title>Designs for generalized linear models with random block effects via information matrix approximations</gtr:title><gtr:parentPublicationTitle>Biometrika</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf78512ab493fe10ecb8a3e22d01f8d2"><gtr:id>bf78512ab493fe10ecb8a3e22d01f8d2</gtr:id><gtr:otherNames>Waite T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3444</gtr:issn><gtr:outcomeId>56bc95c5b10922.82758971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74E8FB8F-EE6F-4B12-B1B3-97E25010F8C7</gtr:id><gtr:title>Optimal blocked minimum-support designs for non-linear models</gtr:title><gtr:parentPublicationTitle>Journal of Statistical Planning and Inference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c934b96401bff0cbb2a4527a77c0d89d"><gtr:id>c934b96401bff0cbb2a4527a77c0d89d</gtr:id><gtr:otherNames>van de Ven P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>54186085d59208.01178079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C1AD38B-0F40-49DE-B28A-9F097B54AB0B</gtr:id><gtr:title>Optimal design for prediction using local linear regression and the DSI-criterion</gtr:title><gtr:parentPublicationTitle>Statistics and Applications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/024e30e720f4332f2a9b3d77dbbf9113"><gtr:id>024e30e720f4332f2a9b3d77dbbf9113</gtr:id><gtr:otherNames>Fisher, V.A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>r_5071420821641136a0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD3C52FF-6396-486A-B96D-2506F6B8ED7C</gtr:id><gtr:title>Emulation of Multivariate Simulators Using Thin-Plate Splines with Application to Atmospheric Dispersion</gtr:title><gtr:parentPublicationTitle>SIAM/ASA Journal on Uncertainty Quantification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03cf6676cb9eccc1bc60eddf2fa936ba"><gtr:id>03cf6676cb9eccc1bc60eddf2fa936ba</gtr:id><gtr:otherNames>Bowman V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d4457141204.92907085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E173F27-7D6F-431C-8834-8551A4882025</gtr:id><gtr:title>A strategy for Bayesian inference for computationally expensive models with application to the estimation of stem cell properties.</gtr:title><gtr:parentPublicationTitle>Biometrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0640257da208e905db9f4ca7f6ca22fb"><gtr:id>0640257da208e905db9f4ca7f6ca22fb</gtr:id><gtr:otherNames>Overstall AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-341X</gtr:issn><gtr:outcomeId>54186032615099.86344902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AE39073-8187-4816-BE3C-1639737F0166</gtr:id><gtr:title>Weighted space-filling designs</gtr:title><gtr:parentPublicationTitle>Journal of Simulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03cf6676cb9eccc1bc60eddf2fa936ba"><gtr:id>03cf6676cb9eccc1bc60eddf2fa936ba</gtr:id><gtr:otherNames>Bowman V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>54186085a100c0.48492405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45D0D679-F2CC-4B0B-85B6-21F2638AD634</gtr:id><gtr:title>Lost in space: design of experiments and scientific exploration in a Hogarth Universe.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5e144f1fb9727d3323e2fa57d19f162"><gtr:id>f5e144f1fb9727d3323e2fa57d19f162</gtr:id><gtr:otherNames>Lendrem DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>56bc962fa2c4f9.13663909</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B73C914E-B6F9-418E-9B1C-F6440C5447AF</gtr:id><gtr:title>Handbook of Uncertainty Quantification</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7284c33dcd450b4d41fa570a391cd461"><gtr:id>7284c33dcd450b4d41fa570a391cd461</gtr:id><gtr:otherNames>Woods D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56bc973e051046.05517424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C08B733D-DDB3-4EA4-ACD4-CDD8BDB17C4A</gtr:id><gtr:title>Bayesian Design of Experiments Using Approximate Coordinate Exchange</gtr:title><gtr:parentPublicationTitle>Technometrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7060ecb3974768556f59427d16cb8e9"><gtr:id>f7060ecb3974768556f59427d16cb8e9</gtr:id><gtr:otherNames>Overstall A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58ac471d93aeb6.01036047</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/J018317/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>DEA11FBC-BEED-4EDD-890B-97D728462D26</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mathematical sciences</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>62309876-5C71-411C-B1A7-1B2907AFB5A8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Statistics &amp; Appl. Probability</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>